Evaluating the safety of diabetes drugs: perspective of a Food and Drug Administration insider.
Misbin
Robert I
RI
Division of Endocrine and Metabolic Drug Products, Food and Drug Administration, Rockville, Maryland, USA. misbinr@cder.fda.gov
D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
D007004:Hypoglycemic Agents